Thetford Mines, Quebec – June 26, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce that Dr. Giuseppe D’Aprano is appointed to the Corporation’s management team as Chief Scientific Officer (CSO) as of June 26, 2019.
- LETTER FROM THE PRESIDENT
- KDA Group selected for 2020 TSX venture top 50 list
- kDa Group develops a technological platform for its subsidiary AlliancePharma
- kDa Group develops a cannabis-based medical products eduction program for pharmacists and technicians
- Expansion of the CanNorth Medic plant for cannabis-based medical products